Ibandronate is a bisphosphonate prescribed to prevent or treat osteoporosis in women after menopause. Bone is a living tissue constantly being remodeled. Bisphosphonates specifically act on bone cells (osteoclasts) to inhibit bone resorption and turnover activity and reduce progressive bone loss and risk for fracture.
Patient Medication Guide
Full Prescribing Information
Financial assistance may be available by calling 877-436-3683.
Ibandronate Injection is Indicated for the treatment of osteoporosis in postmenopausal women
Note: If a dose is missed, reschedule injection administration as soon as possible. Schedule subsequent injections every three months from the date of last injection.
Updated February 2020 - ARP Practice Committee
DISCLAIMER:The information contained in this biologic reference guide is offered solely for purposes of providing health care professionals with a quick and initial reference. Before prescribing or administering any drug contained in this biologic reference guide, health professionals should read the manufacturer’s complete prescribing information in order to be informed of the various clinical considerations to be taken into account. The American College of Rheumatology is providing this information as a benefit and service in furtherance of its educational mission. By providing this information, ACR is not endorsing or recommending any of the listed companies or any of their drugs or other products. The information contained in the biologic reference guides reflect the conclusions of the individual companies and not those of the ACR which specifically disclaims any responsibility or liability for the use of such information and/or for the performance of any of the drugs listed in this biologic reference guide.